RSS
|
Login
|
Register
Home
News
Latest News
People Moves
Business Briefs
Newsletters
Features
Features
Reprints
Issue Archive
Events
Awards
Webcasts
Surveys
Directories
PMD
MM&M Service Directory
Agency Gallery
Direct Marketing Showcase
Medical Education Review
Jobs
About Us
Subscriber Services
Contact Us
Media Information
Editorial Advisory Board
Drug Info
New Drug Dossier
Drug Database
Subscribe
Order Now
Subscriber Services
Newsletters
Home
>
News
> Quadrant names Flomenbaum editor-in-chief
Media Notepad
Quadrant names Flomenbaum editor-in-chief
August 01, 2006
Print
Email
Reprint
Font Size:
A
|
A
|
A
Quadrant HealthCom has named Dr. Neal Flomenbaum editor-in-chief of
Emergency Medicine
. Flomenbaum, who heads emergency medicine at New York-Presbyterian, is a senior editor and author of
Goldfrank's Toxicologic Emergencies
.
From the August 2006 Issue of MMM
Most Popular
Thomson Reuters names five most promising Q1 drugs
Pharma donors favor Obama
'Fully Engaged' docs more open to influence
AstraZeneca teams up with Abbott on Crestor co-promote
Harry and Louise having second thoughts on healthcare
Manhattan Research names top product sites for docs
Stanford prohibits direct commercial CME sponsorship
GSK to make grant info public
Vioxx trial described as marketing stunt
UCB cuts 2,000 jobs, re-tools as a specialty company
Most Emailed
The End of CME as We Know It
Abbott launches Crohn's disease podcasts
Verispan acquired by data rival SDI
AstraZeneca teams up with Abbott on Crestor co-promote
'Fully Engaged' docs more open to influence
Stanford prohibits direct commercial CME sponsorship
Surprise! Massachusetts gift ban is back
Changing Channels
UCB cuts 2,000 jobs, re-tools as a specialty company
Manhattan Research names top product sites for docs
Most Recent
UCB cuts 2,000 jobs, re-tools as a specialty company
GfK drops TNS bid
Stanford prohibits direct commercial CME sponsorship
Manhattan Research names top product sites for docs
Medical Economics overhauls editorial team
GSK to make grant info public
AMM honors top journal ads
Vioxx trial described as marketing stunt
Harry and Louise having second thoughts on healthcare
Thomson Reuters names five most promising Q1 drugs
Popular Tags
Advertising
Agency
Approval
Awards
Brand
Clinical trial
Continuing medical education (CME)
Direct marketing
Education & Awareness
FDA
Government
Launch
Magazine
Marketing & Communications
Marketing Research
Media
New hire
Online
Pharmaceutical
Pipeline
Professional
Promotion
Regulatory
Sales force
Television
Home
|
News
|
Features
|
Events
|
Surveys
|
Lists
|
Directories
|
Jobs
|
About Us
|
Contact Us
|
Subscribe
|
Newsletters
|
PMD
|
Advertise
|
Editorial Advisory Board
|
RSS